Marinexcell utilizes a proprietary stem cell-based technology for the mass production of genuine shrimp, lobster, and crab meat, providing a sustainable alternative to overexploited wild shellfish stocks. This approach addresses the escalating global demand for shellfish while ensuring food free of contaminants, antibiotics, and diseases, thereby preserving marine ecosystems.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Wild shellfish stocks are overexploited, with 90% already depleted, leading to a sharp decline in shrimp, lobster, and crab populations and affecting marine ecosystems. Global demand for shellfish is rapidly increasing, posing a significant challenge to traditional fishing and aquafarming methods.
Solution
Marinexcell is developing a proprietary stem cell-based technology for the mass production of genuine shrimp, lobster, and crab meat. This cultured shellfish meat provides a sustainable alternative to traditional methods, addressing the escalating global demand while minimizing environmental impact and preserving marine ecosystems. The process yields food free of contaminants, antibiotics, and diseases, offering a nutritious and affordable source of shellfish.
Target Audience
The primary target audience includes consumers and businesses seeking sustainable and ethically sourced shellfish alternatives, as well as those concerned about the environmental impact of traditional fishing practices.
Features
- Proprietary stem cell-based technology for shellfish meat production
- Production of genuine shrimp, lobster, and crab meat
- Sustainable alternative to overexploited wild shellfish stocks
- Food free of contaminants, antibiotics, and diseases
- Ecofriendly practices that contribute to mitigating climate change